Portfolio manager Dan LeVan heads Trivalent, a Boston-based international equity boutique that specializes in non-US developed- and emerging-markets strategies under Victory Capital's umbrella.

Portfolio manager Dan LeVan heads Trivalent, a Boston-based international equity boutique that specializes in non-US developed- and emerging-markets strategies under Victory Capital's umbrella.

The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the ...

The agency formulated its advice to manufacturers after coordinating with the CDC and Defense Department. An advisory meeting ...

After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the ...

The Food and Drug Administration has issued recommendations for the composition of influenza shots for the upcoming ...

The Fund seeks long-term growth of capital. The Fund invests at least 80% of its assets in securities of small- to mid-capitalization companies.

Background Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated ...

Boehringer Ingelheim is expanding its Vaxxitek vaccine portfolio with the launch of Vaxitek HVT+IBD+H5, a trivalent poultry vaccine providing protection against H5 avian influenza, also known as bird ...

In 1978, the first trivalent vaccine included two influenza A strains and one influenza B strain. Currently, there are two influenza B lineages circulating; in the latest WHO recommendations ...

VAXXITEK® HVT+IBD+H5 is a new trivalent vaccine for poultry that offers protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in just one shot. H5 avian influenza is a ...